{"id":"noxiptiline","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Antidepressive Agents","category":"pharmacology"},{"label":"Antidepressive Agents, Tricyclic","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Psychotropic Drugs","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"noxiptilin","offLabel":[],"synonyms":["noxiptilin","noxiptiline","noxiptylin","noxiptyline"],"timeline":[],"approvals":[],"brandName":"Noxiptilin","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and proteins or receptors are like keys. Noxiptilin is like a key that fits into a specific lock, allowing it to turn and unlock a particular cellular process. This process can help treat a variety of diseases, but more research is needed to understand exactly how it works.","oneSentence":"Noxiptilin works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Noxiptilin's exact mechanism of action is unknown, but as a small molecule, it is likely to interact with specific biological molecules such as enzymes, receptors, or ion channels to produce a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1975","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NOXIPTILINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:03:10.681352","biosimilars":[],"competitors":[],"genericName":"noxiptiline","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"DF7D3NY7EL","CHEBI":"CHEBI:135232","INN_ID":"2505","UMLSCUI":"C2698505","ChEMBL_ID":"CHEMBL1697689","PUBCHEM_CID":"21087","MESH_SUPPLEMENTAL_RECORD_UI":"C100240"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":11,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Noxiptilin (NOXIPTILINE) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. Further information on its mechanism of action, safety considerations, and availability is not available. More research is needed to understand its potential uses and risks.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}